|
IDXG Interpace Biosciences Inc 1054102 |
| Balance Sheet |
|
Current Assets
|
$10,968,000.00 |
|
Assets
|
$34,549,000.00 |
|
Current Liabilities
|
$4,951,000.00 |
|
Liabilities
|
$11,305,000.00 |
|
Equity
|
$23,244,000.00 |
|
Shares Out
|
27700904.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$381,000.00 |
|
Investing Cash Flow
|
$-198,000.00 |
| Market Analysis |
Market Cap
|
$179,224,848.88 |
|
Price
|
$6.47 |
|
BVPS
|
0.84 |
|
PB
|
7.70 |
|
EPS
|
0.01 |
|
PE
|
2.25 |
|
PS
|
1.22 |
|
FCF
|
$183,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-10-01 09:31:45 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-10-26 10:00:33 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view IDXG documents filed with the SEC.
IDXG Filings
Clear
